In addition, approximately 60% of all gliomas have an amplified gene coding epidermal growth factor receptor (EGFR), which, by binding to epidermal growth factor (EGF), contributes to its increased activity and promotes proliferation and intracellular signaling disorders [29]. The gene discussed is EGF; the disease is central nervous system cancer.